Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Peyvandi

Showing results (401-410 of 611) with videos related to

Pageof 62
Sort By:
Haematologica|August 30, 2008
Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing patternClaudia Dall'Osso, Ilaria Guella, Stefano Duga, et al.
Blood Advances|February 5, 2024
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2AOmid Seidizadeh, Luca Mollica, Serena Zambarbieri, et al.
Blood|February 24, 2006
Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years agoAriella Zivelin, Ronit Mor-Cohen, Victoria Kovalsky, et al.
Internal and Emergency Medicine|May 18, 2024
Bleeding and thrombotic events and intensity of heparin therapy in the two first waves of COVID-19Raffaella Rossio, Mauro Tettamanti, Alessia Antonella Galbussera, et al.
Thrombosis and Haemostasis|October 6, 2023
Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWFOmid Seidizadeh, Alessandro Ciavarella, Luciano Baronciani, et al.
Blood Advances|July 28, 2023
Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapyVincenzo La Mura, Niccolò Bitto, Cecilia Capelli, et al.
American Journal of Hematology|June 11, 2026
Clinical and Laboratory Characterization of Acquired Von Willebrand SyndromeAlessandro Ciavarella, Luciano Baronciani, Omid Seidizadeh, et al.
Blood|April 10, 2016
Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patientsMarcin M Gorski, Kevin Blighe, Luca A Lotta, et al.
Thrombosis and Haemostasis|March 1, 2005
Clinical phenotypes and factor VII genotype in congenital factor VII deficiencyGuglielmo Mariani, Falko H Herrmann, Alberto Dolce, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 9, 2022
Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHCWolfgang Miesbach, Fariba Baghaei, Ana Boban, et al.
Pageof 62

Showing results (401-410 of 611) with videos related to

Sort By:
Pageof 62
Haematologica|August 30, 2008
Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing patternClaudia Dall'Osso, Ilaria Guella, Stefano Duga, et al.
Blood Advances|February 5, 2024
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2AOmid Seidizadeh, Luca Mollica, Serena Zambarbieri, et al.
Blood|February 24, 2006
Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years agoAriella Zivelin, Ronit Mor-Cohen, Victoria Kovalsky, et al.
Internal and Emergency Medicine|May 18, 2024
Bleeding and thrombotic events and intensity of heparin therapy in the two first waves of COVID-19Raffaella Rossio, Mauro Tettamanti, Alessia Antonella Galbussera, et al.
Thrombosis and Haemostasis|October 6, 2023
Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWFOmid Seidizadeh, Alessandro Ciavarella, Luciano Baronciani, et al.
Blood Advances|July 28, 2023
Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapyVincenzo La Mura, Niccolò Bitto, Cecilia Capelli, et al.
American Journal of Hematology|June 11, 2026
Clinical and Laboratory Characterization of Acquired Von Willebrand SyndromeAlessandro Ciavarella, Luciano Baronciani, Omid Seidizadeh, et al.
Blood|April 10, 2016
Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patientsMarcin M Gorski, Kevin Blighe, Luca A Lotta, et al.
Thrombosis and Haemostasis|March 1, 2005
Clinical phenotypes and factor VII genotype in congenital factor VII deficiencyGuglielmo Mariani, Falko H Herrmann, Alberto Dolce, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 9, 2022
Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHCWolfgang Miesbach, Fariba Baghaei, Ana Boban, et al.
Pageof 62